In line with these data, some authors demonstrated that a proportion of CD8+ T cells expressing CXCR5 increased in SARS-CoV-2 infected individuals (71) and enriched in surviving COVID-19 patients compared to those who succumbed to the infection, thereby conferring protection against SARS-CoV-2 infection (72). The gene discussed is CD8A; the disease is COVID-19.